Kristopher W. Krausz
National Cancer Institute(US)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Cancer, Hypoxia, and Metabolism, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Gut microbiota and intestinal FXR mediate the clinical benefits of metformin(2018)981 cited
- → Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity(2013)684 cited
- → Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease(2014)667 cited
- → Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota(2017)642 cited
- → Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction(2015)532 cited
- → Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism(2018)521 cited
- →